← back to search

Ning Xie

Second Affiliated Hospital of Xi'an Jiaotong University · CN
Area of research
Pulmonary and Respiratory Medicine · Cancer Research
Research interest
Research interests include Prostate Cancer Treatment and Research, Cancer-related molecular mechanisms research, Advanced Breast Cancer Therapies, and Natural product bioactivities and synthesis.
h-index
41
citations
6,184
works
396
NIH funding
primary concept
email

Recent publications

RhoB-Rab1A forms a mechanobiology module that couples cytoskeletal organization to nuclear mechanics and β-catenin access in epithelial cells
Pathology - Research and Practice 2026cited by 0position: contributordoi
Completing the Biosynthesis of the Clinically Important Diterpenoid Andrographolide in <i>Andrographis Paniculata</i>
Angewandte Chemie International Edition 2025cited by 6position: middledoi
BEBT-209, a primary CDK4 selective inhibitor, for the treatment of HR+/HER2- advanced breast cancer (BECTOP1): a phase 1, multicentre, open-label study
The Breast 2025cited by 2position: middledoi
Completing the Biosynthesis of the Clinically Important Diterpenoid Andrographolide in <i>Andrographis Paniculata</i>
Angewandte Chemie 2025cited by 2position: middledoi
ARHGAP11A is a potential prognostic biomarker and therapeutic target for pancreatic adenocarcinoma
The International Journal of Biochemistry &amp; Cell Biology 2025cited by 0position: contributordoi
Cell response to mechanical microenvironment cues via Rho signaling: From mechanobiology to mechanomedicine.
2023cited by 57position: contributordoi
Association between Gut Microbiota and Digestive System Cancers: A Bidirectional Two-Sample Mendelian Randomization Study.
2023cited by 28position: contributordoi
High expression of cytoplasmic FOXO3 protein associated with poor prognosis of rectal cancer patients: A study from Swedish clinical trial of preoperative radiotherapy to big database analysis.
2023cited by 2position: contributordoi
The circulating tumor DNA (ctDNA) alteration level predicts therapeutic response in metastatic breast cancer: Novel prognostic indexes based on ctDNA
The Breast 2022cited by 28position: middledoi
The Role of Calcium, 25-Hydroxyvitamin D, and Parathyroid Hormone in Irritable Bowel Syndrome: A Bidirectional Two-Sample Mendelian Randomization Study.
2022cited by 9position: contributordoi
ARL11 correlates with the immunosuppression and poor prognosis in breast cancer: A comprehensive bioinformatics analysis of ARL family members.
2022cited by 5position: contributordoi
Ferulic Acid Ameliorates Alzheimer's Disease-like Pathology and Repairs Cognitive Decline by Preventing Capillary Hypofunction in APP/PS1 Mice
Neurotherapeutics 2021cited by 55position: middledoi
A multicenter analysis of treatment patterns and clinical outcomes of subsequent therapies after progression on palbociclib in HR+/HER2− metastatic breast cancer
Therapeutic Advances in Medical Oncology 2021cited by 41position: middledoi
Real-world effectiveness of eribulin in heavily pretreated patients with metastatic breast cancer in China: a multicenter retrospective study
Therapeutic Advances in Medical Oncology 2021cited by 13position: middledoi
Identification of SRGAP2 as a potential oncogene and a prognostic biomarker in hepatocellular carcinoma.
2021cited by 11position: contributordoi
ARL4C might serve as a prognostic factor and a novel therapeutic target for gastric cancer: bioinformatics analyses and biological experiments.
2021cited by 9position: contributordoi
MicroRNA-302s Might Regulate ARL4C-Mediated Gastric Cancer Progression via p53 Signaling: Bioinformatics Analysis and Experiments Validation.
2021cited by 4position: contributordoi
LIN28B promotes the development of neuroendocrine prostate cancer
Journal of Clinical Investigation 2020cited by 113position: middledoi
Nanoparticles (NPs)‐Meditated LncRNA AFAP1‐AS1 Silencing to Block Wnt/<i>β</i>‐Catenin Signaling Pathway for Synergistic Reversal of Radioresistance and Effective Cancer Radiotherapy
Advanced Science 2020cited by 87position: middledoi
The Critical Role of Dysregulated RhoB Signaling Pathway in Radioresistance of Colorectal Cancer
International Journal of Radiation Oncology*Biology*Physics 2019cited by 44position: middledoi
SRRM4 Drives Neuroendocrine Transdifferentiation of Prostate Adenocarcinoma Under Androgen Receptor Pathway Inhibition
European Urology 2016cited by 180position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 2 papers (2022–2025)Quchang Ouyang · Central South University2 papers (2021–2025) · 2 papers (2025–2025) · 2 papers (2025–2026) · 2 papers (2025–2025)Biyun Wang · Fudan University2 papers (2021–2021)Sifan Wang · Hebei Medical University2 papers (2025–2025)Rui Ge · Fudan University2 papers (2021–2021)Meirong Jia · University of California, Davis2 papers (2025–2025)Chengcheng Gong · Shanghai Medical College of Fudan University2 papers (2021–2021)Chunhong Jiang · Guangzhou University of Chinese Medicine2 papers (2025–2025)Martin Gleave · Prostate Cancer Canada2 papers (2016–2020)Zhe-Yu Hu · Sun Yat-sen University Cancer Center2 papers (2022–2025)Binliang Liu · Dalian Medical University2 papers (2022–2025) · 2 papers (2016–2020) · 2 papers (2025–2025) · 2 papers (2025–2025)Na Liu · Weifang Medical University2 papers (2019–2021)Yinan Li · Guangxi University2 papers (2016–2020)Shilin Chen · Shihezi University2 papers (2025–2025)